General information about company
Scrip code	523489
NSE Symbol	NA
MSEI Symbol	NA
ISIN*	INE889F01017
Name of company	CHENNAI MEENAKSHI MULTISPECIALITY HOSPITAL LIMITED
Type of company
Class of security	Equity
Date of start of financial year	01-04-2018
Date of end of financial year	31-03-2019
Date of board meeting when results were approved	12-11-2018
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	29-10-2018
Description of presentation currency	INR
Level of rounding used in financial results	Lakhs
Reporting Quarter	Half yearly
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited	Unaudited
Segment Reporting	Single segment
Description of single segment	HEALTH CARE SERVICES
Start date and time of board meeting	12-11-2018 16:00
End date and time of board meeting	12-11-2018 17:30
Declaration of unmodified opinion or statement on impact of audit qualification	Not applicable

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-07-2018	01-04-2018
B	Date of end of reporting period	30-09-2018	30-09-2018
C	Whether results are audited or unaudited	Unaudited	Unaudited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	533.72	1075.25
	Other income	9.42	22.16
	Total income	543.14	1097.41
2	Expenses
(a)	Cost of materials consumed	0	0
(b)	Purchases of stock-in-trade	131.01	270.48
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-13.76	-18.71
(d)	Employee benefit expense	108.83	214.27
(e)	Finance costs	33	66.58
(f)	Depreciation, depletion and amortisation expense	29.55	59.34
(f)	Other Expenses
1	Other Expenses	235.83	473.65
10
	Total other expenses	235.83	473.65
	Total expenses	524.46	1065.61

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-07-2018	01-04-2018
B	Date of end of reporting period	30-09-2018	30-09-2018
C	Whether results are audited or unaudited	Unaudited	Unaudited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
3	Total profit before exceptional items and tax	18.68	31.8
4	Exceptional items	0	0
5	Total profit before tax	18.68	31.8
7	Tax expense
8	Current tax	0	0
9	Deferred tax	0	0
10	Total tax expenses	0	0
11	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
14	Net Profit Loss for the period from continuing operations	18.68	31.8
15	Profit (loss) from discontinued operations before tax	0	0
16	Tax expense of discontinued operations	0	0
17	Net profit (loss) from discontinued operation after tax	0	0
19	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
21	Total profit (loss) for period	18.68	31.8
22	Other comprehensive income net of taxes	1.68	2.92

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-07-2018	01-04-2018
B	Date of end of reporting period	30-09-2018	30-09-2018
C	Whether results are audited or unaudited	Unaudited	Unaudited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
23	Total Comprehensive Income for the period	20.36	34.72
24	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
25	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	0	0
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
26	Details of equity share capital
	Paid-up equity share capital	746.89	746.89
	Face value of equity share capital	10	10
27	Details of debt securities
28	Reserves excluding revaluation reserve
29	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	0.25	0.43
	Diluted earnings (loss) per share from continuing operations	0.25	0.43
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	0.25	0.43
	Diluted earnings (loss) per share from continuing and discontinued operations	0.25	0.43
30	Debt equity ratio
31	Debt service coverage ratio
32	Interest service coverage ratio
33	Disclosure of notes on financial results	Textual Information(1)

Text Block

Textual Information(1)

NOTES: 1. The entire operations of the Company relate to only one segment viz; Hospital 2. The above results have been reviewed and recommended for adoption by the Audit Committee and approved by the Board of Directors at their meeting held on 12.11.2018. 3. The Company has adopted the Indian Accounting Standards (Ind AS) w.e..f 1st April, 2017 and accordingly, the financial results have been prepared in accordance with Indian Accounting Standard (Ind AS) as prescribed under Section 133 of the Companies Act, 2013 and other recognised accounting practices and polices to the extent applicable. 4. The Statutory Auditors have carried out a limited review of the financial results. 5. Figures of the previous period / year have been regrouped wherever necessary.

Statement of Asset and Liabilities
Particulars		Half year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2018
Date of end of reporting period		30-09-2018
Whether results are audited or unaudited		Unaudited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	1424.61
	Capital work-in-progress	11.98
	Investment property
	Goodwill	0
	Other intangible assets	0
	Intangible assets under development
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	0
	Trade receivables, non-current
	Loans, non-current	0
	Other non-current financial assets	24.49
	Total non-current financial assets	24.49
	Deferred tax assets (net)
	Other non-current assets
	Total non-current assets	1461.08
2	Current assets
	Inventories	99.22
	Current financial asset
	Current investments	0
	Trade receivables, current	76.39
	Cash and cash equivalents	182.38
	Bank balance other than cash and cash equivalents	0
	Loans, current	0
	Other current financial assets	173.98
	Total current financial assets	432.75
	Current tax assets (net)
	Other current assets	5.52
	Total current assets	537.49

Statement of Asset and Liabilities
Particulars		Half year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2018
Date of end of reporting period		30-09-2018
Whether results are audited or unaudited		Unaudited
Nature of report standalone or consolidated		Standalone
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	1998.57
	Equity and liabilities
	Equity
	Equity attributable to owners of parent
	Equity share capital	746.89
	Other equity	-1129.74
	Total equity attributable to owners of parent	-382.85
	Non controlling interest
	Total equity	-382.85
	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	1147.64
	Trade payables, non-current
	Other non-current financial liabilities
	Total non-current financial liabilities	1147.64
	Provisions, non-current	46.39
	Deferred tax liabilities (net)
	Deferred government grants, Non-current
	Other non-current liabilities
	Total non-current liabilities	1194.03
	Current liabilities
	Current financial liabilities
	Borrowings, current	78.16
	Trade payables, current	169.73
	Other current financial liabilities
	Total current financial liabilities	247.89
	Other current liabilities	933.93
	Provisions, current	5.57
	Current tax liabilities (Net)
	Deferred government grants, Current
	Total current liabilities	1187.39
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	2381.42
	Total equity and liabilites	1998.57
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-07-2018	01-04-2018
Date of end of reporting period		30-09-2018	30-09-2018
Whether accounts are audited or unaudited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets
	Net Segment Asset
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities
	Net Segment Liabilities
	Disclosure of notes on segments